Evoke Pharma, Inc.
EVOK
$10.93
$0.020.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.23M | -5.38M | -5.08M | -5.35M | -6.15M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.13M | 1.14M | 1.14M | 1.29M | 1.31M |
| Change in Net Operating Assets | 772.90K | 623.60K | 62.50K | -1.40M | -487.20K |
| Cash from Operations | -3.32M | -3.62M | -3.88M | -5.46M | -5.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.55M | 6.50M | 6.80M | 14.74M | 11.26M |
| Repurchase of Common Stock | 0.00 | -200.00 | -200.00 | -200.00 | -200.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.50K | 0.00 | 0.00 | -426.30K | -561.10K |
| Cash from Financing | 3.56M | 6.50M | 6.80M | 14.32M | 10.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 237.00K | 2.88M | 2.92M | 8.86M | 5.37M |